# CJC-1295

CJC-1295 has 1 registered human trial. It is marketed for 4 different uses.

**In short**

- 1 registered human trial exists for CJC-1295.
- CJC-1295 is not FDA-approved for any use.
- What has actually been studied: obesity, hiv infections.
- Last checked against ClinicalTrials.gov on 2026-07-27.

## What it is sold for

- Muscle growth
- Fat loss
- Anti-aging via growth hormone
- Sleep quality

## What has actually been tested

- Obesity
- HIV Infections

## Every trial on record

| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| [NCT00267527](https://clinicaltrials.gov/study/NCT00267527) | A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity | Obesity, HIV Infections | Phase 2 | TERMINATED | 120 |

## Common questions

**How many human trials does CJC-1295 have?**
1, each listed above with a link to its original record.

**Is CJC-1295 FDA approved?**
No. It is not approved by the FDA for any indication.

**Where does this data come from?**
ClinicalTrials.gov. We count interventional human studies only. Every trial
links to its original record.

---

*Automated aggregation from public registries. Not medical advice. No physician
has reviewed this page. Source: https://www.whatsactuallyknown.com/compounds/cjc-1295*